Ethan Lange
Concepts (741)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 44 | 2016 | 978 | 3.220 |
Why?
| | Polymorphism, Single Nucleotide | 72 | 2026 | 2137 | 3.070 |
Why?
| | Genetic Linkage | 41 | 2012 | 273 | 2.890 |
Why?
| | Genome-Wide Association Study | 53 | 2026 | 1374 | 2.840 |
Why?
| | Genetic Predisposition to Disease | 72 | 2025 | 2350 | 2.810 |
Why?
| | Genotype | 52 | 2023 | 1847 | 1.340 |
Why?
| | Genome, Human | 17 | 2020 | 420 | 1.250 |
Why?
| | Gene Frequency | 33 | 2022 | 481 | 1.250 |
Why?
| | Body Mass Index | 24 | 2026 | 2419 | 1.160 |
Why?
| | Genetic Variation | 26 | 2021 | 985 | 1.120 |
Why?
| | Obesity | 20 | 2026 | 3070 | 1.050 |
Why?
| | Cardiovascular Diseases | 18 | 2025 | 2172 | 0.980 |
Why?
| | Chromosomes, Human, Pair 17 | 11 | 2019 | 53 | 0.900 |
Why?
| | Exome | 9 | 2016 | 227 | 0.830 |
Why?
| | Hypertension | 8 | 2025 | 1262 | 0.800 |
Why?
| | Pedigree | 26 | 2025 | 515 | 0.800 |
Why?
| | Haplotypes | 27 | 2025 | 495 | 0.790 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2025 | 286 | 0.760 |
Why?
| | Alleles | 21 | 2025 | 886 | 0.760 |
Why?
| | Neuroimaging | 1 | 2025 | 293 | 0.750 |
Why?
| | Chromosome Mapping | 25 | 2010 | 507 | 0.730 |
Why?
| | Models, Genetic | 15 | 2026 | 531 | 0.720 |
Why?
| | Male | 148 | 2026 | 72425 | 0.710 |
Why?
| | Middle Aged | 90 | 2026 | 35968 | 0.690 |
Why?
| | Genetic Loci | 10 | 2019 | 260 | 0.680 |
Why?
| | Imaging, Three-Dimensional | 1 | 2025 | 581 | 0.670 |
Why?
| | Humans | 206 | 2026 | 144665 | 0.670 |
Why?
| | Aged | 77 | 2025 | 25955 | 0.630 |
Why?
| | Quantitative Trait Loci | 10 | 2026 | 374 | 0.600 |
Why?
| | Polymorphism, Genetic | 9 | 2009 | 613 | 0.580 |
Why?
| | Sickle Cell Trait | 4 | 2020 | 15 | 0.580 |
Why?
| | Genetic Association Studies | 9 | 2022 | 369 | 0.570 |
Why?
| | Phenotype | 28 | 2026 | 3147 | 0.560 |
Why?
| | Female | 126 | 2026 | 78301 | 0.550 |
Why?
| | Chromosomes, Human, Pair 8 | 5 | 2019 | 38 | 0.540 |
Why?
| | Adult | 81 | 2026 | 40486 | 0.540 |
Why?
| | Renal Insufficiency, Chronic | 4 | 2025 | 657 | 0.500 |
Why?
| | Genetics, Population | 9 | 2025 | 215 | 0.500 |
Why?
| | Multifactorial Inheritance | 7 | 2026 | 190 | 0.490 |
Why?
| | Apolipoproteins E | 3 | 2015 | 93 | 0.490 |
Why?
| | Diabetes Mellitus, Type 2 | 11 | 2025 | 2573 | 0.490 |
Why?
| | Chromosomes, Human, Pair 6 | 2 | 2015 | 46 | 0.470 |
Why?
| | Atherosclerosis | 5 | 2026 | 409 | 0.460 |
Why?
| | Chromosomes, Human, Pair 11 | 11 | 2011 | 59 | 0.450 |
Why?
| | Fibroblast Growth Factor 5 | 1 | 2015 | 2 | 0.440 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2015 | 10 | 0.440 |
Why?
| | Lipoprotein(a) | 1 | 2015 | 69 | 0.430 |
Why?
| | Blood Pressure | 6 | 2025 | 1766 | 0.430 |
Why?
| | Transferrin | 1 | 2014 | 50 | 0.430 |
Why?
| | Trinucleotide Repeats | 2 | 2008 | 31 | 0.430 |
Why?
| | Ferritins | 1 | 2014 | 70 | 0.420 |
Why?
| | Quantitative Trait, Heritable | 9 | 2021 | 115 | 0.420 |
Why?
| | src-Family Kinases | 1 | 2015 | 92 | 0.420 |
Why?
| | Receptors, Androgen | 3 | 2017 | 148 | 0.420 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2014 | 62 | 0.400 |
Why?
| | Family Health | 10 | 2017 | 191 | 0.400 |
Why?
| | Fibrin Fibrinogen Degradation Products | 2 | 2017 | 92 | 0.390 |
Why?
| | Lod Score | 16 | 2011 | 62 | 0.380 |
Why?
| | Cohort Studies | 24 | 2026 | 5957 | 0.380 |
Why?
| | Ataxia Telangiectasia | 10 | 2004 | 18 | 0.370 |
Why?
| | Magnetic Resonance Imaging | 1 | 2025 | 3887 | 0.370 |
Why?
| | Risk Factors | 28 | 2025 | 10796 | 0.360 |
Why?
| | Iron | 1 | 2014 | 358 | 0.350 |
Why?
| | Whole Genome Sequencing | 2 | 2025 | 184 | 0.350 |
Why?
| | Fibrinogen | 3 | 2025 | 181 | 0.350 |
Why?
| | Microsatellite Repeats | 11 | 2012 | 155 | 0.350 |
Why?
| | Receptors, Urokinase Plasminogen Activator | 2 | 2021 | 15 | 0.340 |
Why?
| | Blood Coagulation | 2 | 2015 | 269 | 0.330 |
Why?
| | Control Groups | 1 | 2010 | 12 | 0.330 |
Why?
| | Chromosomes, Human, Pair 10 | 1 | 2010 | 19 | 0.320 |
Why?
| | Proteins | 7 | 2022 | 1016 | 0.320 |
Why?
| | Weight Gain | 5 | 2016 | 557 | 0.320 |
Why?
| | X Chromosome | 2 | 2000 | 65 | 0.310 |
Why?
| | Young Adult | 24 | 2025 | 14119 | 0.310 |
Why?
| | Genes, BRCA1 | 3 | 2004 | 45 | 0.300 |
Why?
| | Longitudinal Studies | 15 | 2022 | 2942 | 0.300 |
Why?
| | Prospective Studies | 16 | 2025 | 7994 | 0.300 |
Why?
| | Costs and Cost Analysis | 1 | 2010 | 221 | 0.300 |
Why?
| | CpG Islands | 3 | 2025 | 161 | 0.300 |
Why?
| | Germ-Line Mutation | 6 | 2020 | 176 | 0.290 |
Why?
| | Malocclusion, Angle Class III | 1 | 2009 | 2 | 0.290 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 2009 | 35 | 0.290 |
Why?
| | Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2020 | 76 | 0.290 |
Why?
| | C-Reactive Protein | 5 | 2020 | 420 | 0.290 |
Why?
| | Proteome | 2 | 2025 | 515 | 0.290 |
Why?
| | Linkage Disequilibrium | 12 | 2017 | 249 | 0.290 |
Why?
| | Glomerular Filtration Rate | 5 | 2024 | 764 | 0.290 |
Why?
| | Mendelian Randomization Analysis | 3 | 2025 | 54 | 0.280 |
Why?
| | Gastrointestinal Microbiome | 3 | 2026 | 771 | 0.270 |
Why?
| | Case-Control Studies | 17 | 2025 | 3603 | 0.270 |
Why?
| | Genetic Markers | 19 | 2017 | 332 | 0.270 |
Why?
| | Aged, 80 and over | 17 | 2025 | 8283 | 0.270 |
Why?
| | Tumor Suppressor Proteins | 5 | 2016 | 319 | 0.270 |
Why?
| | Veterans | 4 | 2025 | 1614 | 0.260 |
Why?
| | Adiponectin | 5 | 2011 | 240 | 0.250 |
Why?
| | Lipopolysaccharide Receptors | 2 | 2021 | 87 | 0.250 |
Why?
| | Mississippi | 4 | 2025 | 28 | 0.250 |
Why?
| | DNA Methylation | 4 | 2025 | 664 | 0.250 |
Why?
| | Asthma | 6 | 2025 | 1774 | 0.250 |
Why?
| | United States | 27 | 2025 | 16018 | 0.240 |
Why?
| | Alzheimer Disease | 2 | 2023 | 622 | 0.240 |
Why?
| | Genetic Pleiotropy | 2 | 2016 | 30 | 0.240 |
Why?
| | Fibrinolysis | 1 | 2008 | 164 | 0.240 |
Why?
| | Age of Onset | 6 | 2014 | 551 | 0.240 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2006 | 50 | 0.240 |
Why?
| | Anesthesia, Obstetrical | 1 | 2025 | 30 | 0.230 |
Why?
| | Postpartum Hemorrhage | 1 | 2025 | 28 | 0.230 |
Why?
| | Mutation, Missense | 7 | 2018 | 338 | 0.230 |
Why?
| | Chromosomes, Human, Pair 20 | 4 | 2011 | 17 | 0.220 |
Why?
| | Adolescent | 29 | 2025 | 22405 | 0.220 |
Why?
| | Kidney | 3 | 2023 | 1495 | 0.220 |
Why?
| | Apolipoprotein L1 | 2 | 2023 | 14 | 0.220 |
Why?
| | Genetic Techniques | 2 | 2004 | 67 | 0.220 |
Why?
| | Inheritance Patterns | 1 | 2004 | 44 | 0.210 |
Why?
| | RNA Splicing | 1 | 2026 | 286 | 0.210 |
Why?
| | Delivery, Obstetric | 1 | 2025 | 161 | 0.210 |
Why?
| | Atrial Fibrillation | 2 | 2022 | 555 | 0.210 |
Why?
| | Observer Variation | 1 | 2025 | 355 | 0.210 |
Why?
| | Precision Medicine | 2 | 2026 | 454 | 0.210 |
Why?
| | Fasting | 4 | 2018 | 275 | 0.210 |
Why?
| | Sequence Analysis, DNA | 7 | 2016 | 828 | 0.210 |
Why?
| | Skin Diseases | 1 | 2025 | 151 | 0.200 |
Why?
| | Homocysteine | 2 | 2018 | 152 | 0.200 |
Why?
| | Genetics | 1 | 2004 | 23 | 0.200 |
Why?
| | Coronary Artery Disease | 4 | 2018 | 743 | 0.200 |
Why?
| | Blood Proteins | 1 | 2025 | 233 | 0.200 |
Why?
| | Glomerulosclerosis, Focal Segmental | 1 | 2023 | 43 | 0.200 |
Why?
| | Epigenesis, Genetic | 3 | 2025 | 669 | 0.200 |
Why?
| | Blood Glucose | 6 | 2021 | 2326 | 0.190 |
Why?
| | Homeodomain Proteins | 3 | 2012 | 523 | 0.190 |
Why?
| | Chromosomes, Human, Pair 1 | 5 | 2009 | 79 | 0.190 |
Why?
| | Chronic Periodontitis | 2 | 2013 | 5 | 0.190 |
Why?
| | Dementia, Vascular | 1 | 2022 | 21 | 0.190 |
Why?
| | Nuclear Proteins | 3 | 2014 | 741 | 0.190 |
Why?
| | Life Style | 1 | 2025 | 481 | 0.190 |
Why?
| | Gene Expression Profiling | 2 | 2026 | 1766 | 0.180 |
Why?
| | DNA, Neoplasm | 5 | 2014 | 158 | 0.180 |
Why?
| | Diabetic Neuropathies | 1 | 2023 | 99 | 0.180 |
Why?
| | Software | 4 | 2016 | 695 | 0.180 |
Why?
| | Polymerase Chain Reaction | 8 | 2012 | 1047 | 0.180 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2022 | 122 | 0.180 |
Why?
| | Smoking | 2 | 2021 | 1467 | 0.170 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2020 | 337 | 0.170 |
Why?
| | Aging, Premature | 1 | 2021 | 16 | 0.170 |
Why?
| | Obesity, Morbid | 1 | 2025 | 288 | 0.170 |
Why?
| | Overweight | 1 | 2026 | 606 | 0.170 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 2 | 2012 | 35 | 0.170 |
Why?
| | Chromosomes, Human, X | 3 | 2015 | 76 | 0.170 |
Why?
| | Phenylketonurias | 1 | 2021 | 15 | 0.170 |
Why?
| | Linear Models | 4 | 2021 | 845 | 0.170 |
Why?
| | Age Factors | 12 | 2021 | 3329 | 0.160 |
Why?
| | Receptors, Adiponectin | 2 | 2011 | 22 | 0.160 |
Why?
| | Nutrition Surveys | 4 | 2018 | 280 | 0.160 |
Why?
| | Hypoglycemia | 1 | 2025 | 479 | 0.160 |
Why?
| | Skin | 1 | 2025 | 762 | 0.160 |
Why?
| | Carcinoma | 3 | 2010 | 224 | 0.160 |
Why?
| | Risk Assessment | 11 | 2021 | 3729 | 0.160 |
Why?
| | Epigenomics | 1 | 2021 | 112 | 0.160 |
Why?
| | Lipids | 1 | 2025 | 706 | 0.160 |
Why?
| | Weight Loss | 1 | 2026 | 839 | 0.160 |
Why?
| | Mutation | 9 | 2014 | 4081 | 0.160 |
Why?
| | Sensitivity and Specificity | 1 | 2025 | 1995 | 0.160 |
Why?
| | Chemokine CXCL10 | 1 | 2020 | 39 | 0.160 |
Why?
| | Gene Expression Regulation | 3 | 2026 | 2591 | 0.160 |
Why?
| | Statistics, Nonparametric | 4 | 2017 | 427 | 0.150 |
Why?
| | Lymphadenopathy | 1 | 2019 | 8 | 0.150 |
Why?
| | Zinc Fingers | 2 | 2017 | 50 | 0.150 |
Why?
| | Prognosis | 9 | 2021 | 4312 | 0.150 |
Why?
| | Adiposity | 2 | 2017 | 529 | 0.150 |
Why?
| | Biomarkers | 7 | 2023 | 4261 | 0.150 |
Why?
| | Antigens, CD | 1 | 2022 | 552 | 0.150 |
Why?
| | DNA-Binding Proteins | 7 | 2020 | 1484 | 0.150 |
Why?
| | Transcriptome | 1 | 2026 | 1036 | 0.150 |
Why?
| | Factor VIII | 1 | 2020 | 105 | 0.150 |
Why?
| | Genetic Testing | 4 | 2009 | 480 | 0.150 |
Why?
| | Repressor Proteins | 3 | 2014 | 428 | 0.150 |
Why?
| | Computer Simulation | 6 | 2021 | 1021 | 0.150 |
Why?
| | Renal Insufficiency | 1 | 2021 | 172 | 0.140 |
Why?
| | Trabeculectomy | 1 | 2000 | 75 | 0.140 |
Why?
| | International Cooperation | 5 | 2011 | 197 | 0.140 |
Why?
| | Algorithms | 4 | 2025 | 1843 | 0.140 |
Why?
| | Neoplasm, Residual | 1 | 2019 | 139 | 0.140 |
Why?
| | Pediatric Obesity | 2 | 2017 | 637 | 0.140 |
Why?
| | Epidemiologic Studies | 1 | 2019 | 68 | 0.140 |
Why?
| | Exercise | 4 | 2016 | 2183 | 0.140 |
Why?
| | Incidence | 7 | 2021 | 2892 | 0.140 |
Why?
| | Adolescent Health | 2 | 2015 | 37 | 0.140 |
Why?
| | Cell Cycle Proteins | 4 | 2015 | 628 | 0.140 |
Why?
| | Mortality | 1 | 2021 | 377 | 0.140 |
Why?
| | alpha-Globins | 1 | 2018 | 9 | 0.140 |
Why?
| | Observational Studies as Topic | 1 | 2019 | 131 | 0.140 |
Why?
| | Lymphoma | 1 | 2020 | 233 | 0.140 |
Why?
| | Hemoglobin, Sickle | 1 | 2018 | 19 | 0.140 |
Why?
| | Reproducibility of Results | 2 | 2025 | 3414 | 0.140 |
Why?
| | Thromboplastin | 2 | 2017 | 64 | 0.140 |
Why?
| | Gene Pool | 1 | 2017 | 4 | 0.140 |
Why?
| | China | 2 | 2018 | 269 | 0.130 |
Why?
| | Antithrombin III | 1 | 2017 | 18 | 0.130 |
Why?
| | Child | 19 | 2022 | 22599 | 0.130 |
Why?
| | Health Surveys | 2 | 2018 | 517 | 0.130 |
Why?
| | Receptors, LDL | 2 | 2014 | 53 | 0.130 |
Why?
| | Hemoglobins, Abnormal | 1 | 2017 | 8 | 0.130 |
Why?
| | Brain Ischemia | 2 | 2015 | 358 | 0.130 |
Why?
| | Mitral Valve Prolapse | 1 | 2017 | 9 | 0.130 |
Why?
| | Cross-Sectional Studies | 9 | 2025 | 5869 | 0.130 |
Why?
| | Gene Expression | 1 | 2022 | 1476 | 0.130 |
Why?
| | Proportional Hazards Models | 7 | 2020 | 1322 | 0.130 |
Why?
| | Factor VIIa | 1 | 2017 | 43 | 0.130 |
Why?
| | Fatty Liver | 1 | 2020 | 250 | 0.130 |
Why?
| | Leukocytes | 2 | 2016 | 294 | 0.130 |
Why?
| | Body Height | 2 | 2017 | 199 | 0.130 |
Why?
| | Blood Platelets | 2 | 2016 | 379 | 0.130 |
Why?
| | Diabetes Mellitus | 1 | 2025 | 1076 | 0.120 |
Why?
| | Escherichia coli O104 | 1 | 2016 | 1 | 0.120 |
Why?
| | Logistic Models | 4 | 2025 | 2114 | 0.120 |
Why?
| | Interferon-gamma | 1 | 2020 | 781 | 0.120 |
Why?
| | Glaucoma | 1 | 2000 | 247 | 0.120 |
Why?
| | Schizophrenia | 5 | 2007 | 443 | 0.120 |
Why?
| | Cattle Diseases | 1 | 2016 | 26 | 0.120 |
Why?
| | Cadmium | 1 | 2016 | 68 | 0.120 |
Why?
| | Erythropoiesis | 1 | 2016 | 57 | 0.120 |
Why?
| | Motivation | 1 | 2021 | 601 | 0.120 |
Why?
| | Immune System Diseases | 1 | 2016 | 38 | 0.120 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2009 | 317 | 0.120 |
Why?
| | Hypoglycemic Agents | 1 | 2025 | 1388 | 0.120 |
Why?
| | Factor XII | 1 | 2015 | 5 | 0.120 |
Why?
| | Disease | 1 | 2016 | 98 | 0.120 |
Why?
| | Antihypertensive Agents | 1 | 2020 | 512 | 0.120 |
Why?
| | Escherichia coli Infections | 1 | 2016 | 126 | 0.120 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2015 | 751 | 0.110 |
Why?
| | Chromosomes, Human, Y | 1 | 2015 | 37 | 0.110 |
Why?
| | Receptors, Neurokinin-3 | 1 | 2015 | 8 | 0.110 |
Why?
| | Laminin | 1 | 2015 | 70 | 0.110 |
Why?
| | Microbiota | 1 | 2023 | 782 | 0.110 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2015 | 80 | 0.110 |
Why?
| | Cholesterol, LDL | 2 | 2014 | 359 | 0.110 |
Why?
| | Calcium-Binding Proteins | 2 | 2013 | 222 | 0.110 |
Why?
| | Menarche | 1 | 2015 | 52 | 0.110 |
Why?
| | Motor Activity | 2 | 2013 | 723 | 0.110 |
Why?
| | Gene-Environment Interaction | 1 | 2016 | 177 | 0.110 |
Why?
| | Mutation Rate | 1 | 2015 | 30 | 0.110 |
Why?
| | Chromosomes, Human, Pair 5 | 2 | 2012 | 28 | 0.110 |
Why?
| | Chromosomes, Human, Pair 12 | 2 | 2019 | 21 | 0.110 |
Why?
| | Apolipoproteins A | 1 | 2014 | 18 | 0.110 |
Why?
| | Epistasis, Genetic | 1 | 2015 | 65 | 0.110 |
Why?
| | Immunoglobulins | 1 | 2015 | 160 | 0.110 |
Why?
| | Energy Intake | 1 | 2017 | 501 | 0.110 |
Why?
| | Immunotherapy | 1 | 2019 | 662 | 0.110 |
Why?
| | Thrombin | 1 | 2015 | 167 | 0.110 |
Why?
| | Membrane Proteins | 3 | 2016 | 1159 | 0.110 |
Why?
| | Africa | 2 | 2020 | 118 | 0.110 |
Why?
| | Energy Metabolism | 2 | 2017 | 927 | 0.110 |
Why?
| | Insulin Resistance | 2 | 2021 | 1241 | 0.100 |
Why?
| | CD36 Antigens | 1 | 2014 | 32 | 0.100 |
Why?
| | DNA, Mitochondrial | 1 | 2015 | 212 | 0.100 |
Why?
| | Germany | 4 | 2021 | 138 | 0.100 |
Why?
| | RNA, Long Noncoding | 1 | 2016 | 172 | 0.100 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2015 | 191 | 0.100 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2013 | 28 | 0.100 |
Why?
| | Penetrance | 2 | 2015 | 30 | 0.100 |
Why?
| | CARD Signaling Adaptor Proteins | 1 | 2013 | 22 | 0.100 |
Why?
| | Anemia, Sickle Cell | 1 | 2018 | 312 | 0.100 |
Why?
| | Diabetes, Gestational | 1 | 2017 | 303 | 0.100 |
Why?
| | Philippines | 5 | 2011 | 51 | 0.100 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2016 | 426 | 0.100 |
Why?
| | Residence Characteristics | 1 | 2016 | 374 | 0.100 |
Why?
| | Blood Cells | 1 | 2012 | 38 | 0.090 |
Why?
| | Periodontium | 1 | 2012 | 3 | 0.090 |
Why?
| | Meta-Analysis as Topic | 4 | 2014 | 170 | 0.090 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2013 | 253 | 0.090 |
Why?
| | Autoantigens | 1 | 2015 | 425 | 0.090 |
Why?
| | Time Factors | 6 | 2021 | 7140 | 0.090 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 1961 | 0.090 |
Why?
| | Interleukin-18 | 1 | 2013 | 234 | 0.090 |
Why?
| | Glutathione Transferase | 1 | 2012 | 96 | 0.090 |
Why?
| | Promoter Regions, Genetic | 3 | 2006 | 1246 | 0.090 |
Why?
| | Societies, Medical | 2 | 2025 | 890 | 0.090 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2019 | 685 | 0.090 |
Why?
| | Methyltransferases | 1 | 2012 | 75 | 0.090 |
Why?
| | Receptors, Immunologic | 2 | 2003 | 206 | 0.090 |
Why?
| | Arsenic | 1 | 2012 | 65 | 0.090 |
Why?
| | Chromosomes, Human, Pair 4 | 1 | 2011 | 25 | 0.090 |
Why?
| | Factor VII | 1 | 2011 | 24 | 0.090 |
Why?
| | Sample Size | 3 | 2021 | 120 | 0.080 |
Why?
| | Metagenome | 1 | 2012 | 149 | 0.080 |
Why?
| | RNA-Binding Proteins | 1 | 2015 | 461 | 0.080 |
Why?
| | Indians, North American | 1 | 2016 | 597 | 0.080 |
Why?
| | Chromosomes, Human, Pair 22 | 2 | 2010 | 46 | 0.080 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2017 | 641 | 0.080 |
Why?
| | Homozygote | 3 | 2012 | 200 | 0.080 |
Why?
| | Kininogen, Low-Molecular-Weight | 1 | 2010 | 2 | 0.080 |
Why?
| | Kininogen, High-Molecular-Weight | 1 | 2010 | 3 | 0.080 |
Why?
| | Kininogens | 1 | 2010 | 6 | 0.080 |
Why?
| | Mathematical Computing | 1 | 2010 | 11 | 0.080 |
Why?
| | TCF Transcription Factors | 1 | 2010 | 19 | 0.080 |
Why?
| | Population | 1 | 2010 | 30 | 0.080 |
Why?
| | Nandrolone | 1 | 2010 | 3 | 0.080 |
Why?
| | Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2010 | 4 | 0.080 |
Why?
| | Malawi | 1 | 2010 | 57 | 0.080 |
Why?
| | Ethinyl Estradiol | 1 | 2010 | 16 | 0.080 |
Why?
| | Erythrocytes | 1 | 2016 | 750 | 0.080 |
Why?
| | Cystic Fibrosis | 2 | 2011 | 1166 | 0.080 |
Why?
| | Molecular Epidemiology | 2 | 2022 | 73 | 0.080 |
Why?
| | Transcription Factor 7-Like 2 Protein | 2 | 2025 | 26 | 0.080 |
Why?
| | Contraceptives, Oral, Hormonal | 1 | 2010 | 30 | 0.080 |
Why?
| | Breast Neoplasms | 4 | 2004 | 2365 | 0.080 |
Why?
| | Carbohydrate Metabolism | 1 | 2010 | 58 | 0.080 |
Why?
| | Family | 4 | 2006 | 685 | 0.080 |
Why?
| | Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 3 | 2016 | 25 | 0.080 |
Why?
| | RNA Helicases | 1 | 2009 | 30 | 0.080 |
Why?
| | Peptidyl-Dipeptidase A | 2 | 2009 | 56 | 0.080 |
Why?
| | Heterozygote | 3 | 2016 | 313 | 0.070 |
Why?
| | WW Domain-Containing Oxidoreductase | 1 | 2009 | 3 | 0.070 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2012 | 260 | 0.070 |
Why?
| | Maxilla | 1 | 2009 | 36 | 0.070 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2009 | 43 | 0.070 |
Why?
| | Heart Failure | 1 | 2022 | 2324 | 0.070 |
Why?
| | Glucose Intolerance | 1 | 2010 | 142 | 0.070 |
Why?
| | Cadherins | 1 | 2010 | 200 | 0.070 |
Why?
| | Genes, Recessive | 4 | 2004 | 78 | 0.070 |
Why?
| | Cephalometry | 1 | 2009 | 30 | 0.070 |
Why?
| | Myocardial Infarction | 2 | 2014 | 1209 | 0.070 |
Why?
| | Genes, Homeobox | 1 | 2009 | 50 | 0.070 |
Why?
| | Collagen Type II | 1 | 2009 | 54 | 0.070 |
Why?
| | Triglycerides | 2 | 2025 | 517 | 0.070 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2009 | 85 | 0.070 |
Why?
| | Prostate-Specific Antigen | 2 | 2007 | 162 | 0.070 |
Why?
| | Oxidoreductases | 1 | 2009 | 95 | 0.070 |
Why?
| | Feces | 2 | 2025 | 513 | 0.070 |
Why?
| | alpha 1-Antitrypsin | 1 | 2009 | 102 | 0.070 |
Why?
| | 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2008 | 7 | 0.070 |
Why?
| | Adolescent Behavior | 1 | 2013 | 497 | 0.070 |
Why?
| | Stroke | 2 | 2015 | 1262 | 0.070 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 1 | 2008 | 26 | 0.070 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 2008 | 25 | 0.070 |
Why?
| | Psoriasis | 2 | 2002 | 113 | 0.070 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 2 | 2020 | 103 | 0.070 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2008 | 85 | 0.070 |
Why?
| | Environmental Exposure | 1 | 2012 | 574 | 0.070 |
Why?
| | HLA-DR2 Antigen | 1 | 2007 | 8 | 0.060 |
Why?
| | Interleukin-6 | 2 | 2009 | 770 | 0.060 |
Why?
| | Genes, Dominant | 2 | 2004 | 100 | 0.060 |
Why?
| | Prediabetic State | 1 | 2010 | 247 | 0.060 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2008 | 161 | 0.060 |
Why?
| | HLA-DR3 Antigen | 1 | 2007 | 76 | 0.060 |
Why?
| | BRCA1 Protein | 1 | 2007 | 82 | 0.060 |
Why?
| | Europe | 1 | 2008 | 419 | 0.060 |
Why?
| | Neural Cell Adhesion Molecules | 1 | 2006 | 38 | 0.060 |
Why?
| | Prostatic Intraepithelial Neoplasia | 1 | 2006 | 9 | 0.060 |
Why?
| | High-Throughput Nucleotide Sequencing | 3 | 2016 | 552 | 0.060 |
Why?
| | 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2006 | 8 | 0.060 |
Why?
| | Liver Diseases | 1 | 2009 | 304 | 0.060 |
Why?
| | Mixed Function Oxygenases | 1 | 2006 | 49 | 0.060 |
Why?
| | Dermoscopy | 1 | 2025 | 11 | 0.060 |
Why?
| | Perinatology | 1 | 2025 | 12 | 0.060 |
Why?
| | Genes, Lethal | 1 | 2005 | 30 | 0.060 |
Why?
| | Transcription Factors | 3 | 2012 | 1726 | 0.060 |
Why?
| | Pimozide | 2 | 1976 | 3 | 0.060 |
Why?
| | Genomic Imprinting | 1 | 2005 | 26 | 0.060 |
Why?
| | Sex Factors | 5 | 2017 | 2104 | 0.060 |
Why?
| | Organ Specificity | 1 | 2026 | 311 | 0.060 |
Why?
| | National Longitudinal Study of Adolescent Health | 2 | 2016 | 9 | 0.060 |
Why?
| | Pregnancy | 4 | 2025 | 7122 | 0.060 |
Why?
| | Labor, Obstetric | 1 | 2025 | 67 | 0.060 |
Why?
| | Genomics | 2 | 2007 | 831 | 0.060 |
Why?
| | Follow-Up Studies | 4 | 2014 | 5414 | 0.060 |
Why?
| | Chromosomes | 1 | 2005 | 108 | 0.060 |
Why?
| | Kaplan-Meier Estimate | 2 | 2019 | 967 | 0.050 |
Why?
| | Infant | 5 | 2010 | 10022 | 0.050 |
Why?
| | Population Groups | 1 | 2025 | 56 | 0.050 |
Why?
| | Multigene Family | 1 | 2005 | 210 | 0.050 |
Why?
| | Warfarin | 1 | 2006 | 173 | 0.050 |
Why?
| | History, 21st Century | 1 | 2025 | 220 | 0.050 |
Why?
| | North America | 1 | 2025 | 312 | 0.050 |
Why?
| | Serum | 1 | 2005 | 57 | 0.050 |
Why?
| | Immunoglobulin E | 2 | 2003 | 315 | 0.050 |
Why?
| | Platelet Count | 2 | 2016 | 94 | 0.050 |
Why?
| | Siblings | 3 | 2010 | 195 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2007 | 435 | 0.050 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2007 | 238 | 0.050 |
Why?
| | Survival Analysis | 2 | 2020 | 1370 | 0.050 |
Why?
| | Hematocrit | 2 | 2016 | 108 | 0.050 |
Why?
| | History, 20th Century | 1 | 2025 | 327 | 0.050 |
Why?
| | Lung Diseases | 1 | 2011 | 781 | 0.050 |
Why?
| | Canada | 1 | 2025 | 432 | 0.050 |
Why?
| | Receptor, Melanocortin, Type 4 | 2 | 2016 | 17 | 0.050 |
Why?
| | Fertility | 1 | 2005 | 166 | 0.050 |
Why?
| | Neoplasm Invasiveness | 1 | 2006 | 503 | 0.050 |
Why?
| | Michigan | 3 | 2012 | 137 | 0.050 |
Why?
| | Physical Fitness | 1 | 2005 | 207 | 0.050 |
Why?
| | Apolipoproteins | 1 | 2023 | 38 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2026 | 442 | 0.050 |
Why?
| | DNA Mutational Analysis | 3 | 2016 | 409 | 0.050 |
Why?
| | Intermediate Filaments | 1 | 2023 | 25 | 0.050 |
Why?
| | Hypersensitivity, Immediate | 1 | 2003 | 41 | 0.050 |
Why?
| | Syndrome | 3 | 2017 | 379 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 1 | 2026 | 572 | 0.050 |
Why?
| | Meiosis | 1 | 2004 | 101 | 0.050 |
Why?
| | Asialoglycoprotein Receptor | 1 | 2022 | 6 | 0.050 |
Why?
| | Neurofilament Proteins | 1 | 2023 | 79 | 0.050 |
Why?
| | Tropomyosin | 1 | 2002 | 10 | 0.050 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2003 | 130 | 0.050 |
Why?
| | Cognition Disorders | 1 | 2007 | 539 | 0.050 |
Why?
| | Endoribonucleases | 1 | 2003 | 80 | 0.050 |
Why?
| | Insulin | 4 | 2021 | 2502 | 0.050 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2022 | 65 | 0.050 |
Why?
| | Risk | 3 | 2010 | 911 | 0.040 |
Why?
| | Genome | 1 | 2004 | 305 | 0.040 |
Why?
| | Hemoglobins | 2 | 2016 | 381 | 0.040 |
Why?
| | Osteoarthritis, Knee | 1 | 2005 | 279 | 0.040 |
Why?
| | Pilot Projects | 2 | 2022 | 1886 | 0.040 |
Why?
| | Mastectomy, Segmental | 1 | 2002 | 107 | 0.040 |
Why?
| | Disease Progression | 2 | 2020 | 2847 | 0.040 |
Why?
| | Amino Acid Substitution | 3 | 2012 | 303 | 0.040 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 2002 | 88 | 0.040 |
Why?
| | Inflammation | 2 | 2013 | 2870 | 0.040 |
Why?
| | Ultrasonography | 1 | 2025 | 776 | 0.040 |
Why?
| | Data Interpretation, Statistical | 2 | 2015 | 368 | 0.040 |
Why?
| | Causality | 1 | 2021 | 126 | 0.040 |
Why?
| | Netherlands | 1 | 2021 | 82 | 0.040 |
Why?
| | alpha Karyopherins | 1 | 2020 | 11 | 0.040 |
Why?
| | Adenocarcinoma | 1 | 2008 | 923 | 0.040 |
Why?
| | Kidney Function Tests | 1 | 2021 | 156 | 0.040 |
Why?
| | Biomarkers, Tumor | 2 | 2006 | 1319 | 0.040 |
Why?
| | Disease Susceptibility | 4 | 2009 | 342 | 0.040 |
Why?
| | Anticoagulants | 1 | 2006 | 729 | 0.040 |
Why?
| | Tripartite Motif Proteins | 1 | 2020 | 39 | 0.040 |
Why?
| | HLA Antigens | 1 | 2002 | 235 | 0.040 |
Why?
| | Mitogens | 1 | 1980 | 55 | 0.040 |
Why?
| | Platelet Factor 4 | 1 | 1980 | 36 | 0.040 |
Why?
| | Tobacco Smoke Pollution | 1 | 2003 | 227 | 0.040 |
Why?
| | Metabolomics | 1 | 2026 | 724 | 0.040 |
Why?
| | Dioxygenases | 1 | 2020 | 36 | 0.040 |
Why?
| | Growth Substances | 1 | 1980 | 138 | 0.040 |
Why?
| | Cell Self Renewal | 1 | 2020 | 52 | 0.040 |
Why?
| | Drosophila Proteins | 1 | 2002 | 213 | 0.040 |
Why?
| | Cell Adhesion Molecules | 2 | 2017 | 178 | 0.040 |
Why?
| | Codon, Nonsense | 2 | 2015 | 44 | 0.040 |
Why?
| | Blood Coagulation Factors | 1 | 1980 | 60 | 0.040 |
Why?
| | Body Weight | 3 | 2010 | 968 | 0.040 |
Why?
| | Africa, Western | 1 | 2020 | 21 | 0.040 |
Why?
| | Calcinosis | 1 | 2002 | 234 | 0.040 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2020 | 75 | 0.040 |
Why?
| | United Kingdom | 1 | 2021 | 337 | 0.040 |
Why?
| | Albuminuria | 1 | 2020 | 190 | 0.040 |
Why?
| | Neoplasm Staging | 2 | 2020 | 1465 | 0.040 |
Why?
| | von Willebrand Factor | 1 | 2020 | 85 | 0.040 |
Why?
| | Diabetic Nephropathies | 1 | 2003 | 318 | 0.040 |
Why?
| | Models, Statistical | 1 | 2004 | 677 | 0.040 |
Why?
| | Machine Learning | 1 | 2025 | 587 | 0.040 |
Why?
| | Autoantibodies | 1 | 2007 | 1505 | 0.040 |
Why?
| | Bayes Theorem | 2 | 2016 | 426 | 0.040 |
Why?
| | Idarubicin | 1 | 2019 | 5 | 0.040 |
Why?
| | Exons | 3 | 2006 | 362 | 0.040 |
Why?
| | Neoplasm Grading | 1 | 2020 | 310 | 0.040 |
Why?
| | Creatinine | 1 | 2020 | 509 | 0.040 |
Why?
| | Abdomen | 1 | 2019 | 141 | 0.040 |
Why?
| | Chromosome Breakage | 1 | 1998 | 23 | 0.040 |
Why?
| | Induction Chemotherapy | 1 | 2019 | 87 | 0.040 |
Why?
| | Etoposide | 1 | 2019 | 168 | 0.040 |
Why?
| | alpha-Thalassemia | 1 | 2018 | 5 | 0.030 |
Why?
| | Infant, Newborn | 3 | 2017 | 6399 | 0.030 |
Why?
| | Erythrocytes, Abnormal | 1 | 2018 | 14 | 0.030 |
Why?
| | Skin Neoplasms | 1 | 2025 | 850 | 0.030 |
Why?
| | Brain | 3 | 2007 | 2933 | 0.030 |
Why?
| | Cognition | 1 | 2006 | 1263 | 0.030 |
Why?
| | Prostate | 2 | 2012 | 158 | 0.030 |
Why?
| | Endothelial Protein C Receptor | 1 | 2017 | 6 | 0.030 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2017 | 4 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2019 | 768 | 0.030 |
Why?
| | Azacitidine | 1 | 2019 | 157 | 0.030 |
Why?
| | Cytokines | 1 | 2005 | 2045 | 0.030 |
Why?
| | Research Design | 1 | 2004 | 1129 | 0.030 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2020 | 454 | 0.030 |
Why?
| | Pseudorabies | 1 | 1997 | 1 | 0.030 |
Why?
| | Herpesvirus 1, Suid | 1 | 1997 | 2 | 0.030 |
Why?
| | Intraocular Pressure | 1 | 2000 | 326 | 0.030 |
Why?
| | DNA | 2 | 2022 | 1447 | 0.030 |
Why?
| | Homeostasis | 1 | 2021 | 639 | 0.030 |
Why?
| | Procollagen N-Endopeptidase | 1 | 2017 | 7 | 0.030 |
Why?
| | ADAMTS Proteins | 1 | 2017 | 5 | 0.030 |
Why?
| | Interleukin-11 Receptor alpha Subunit | 1 | 2017 | 4 | 0.030 |
Why?
| | NADPH Oxidase 4 | 1 | 2017 | 7 | 0.030 |
Why?
| | Hematopoietic Stem Cells | 1 | 2020 | 419 | 0.030 |
Why?
| | Pyrophosphatases | 1 | 1997 | 26 | 0.030 |
Why?
| | Proto-Oncogene Proteins | 1 | 2020 | 619 | 0.030 |
Why?
| | Treatment Outcome | 3 | 2019 | 11734 | 0.030 |
Why?
| | Somatomedins | 1 | 2017 | 28 | 0.030 |
Why?
| | DNA Copy Number Variations | 1 | 2018 | 184 | 0.030 |
Why?
| | Kidney Failure, Chronic | 1 | 2003 | 597 | 0.030 |
Why?
| | Pregnancy-Associated Plasma Protein-A | 1 | 2017 | 14 | 0.030 |
Why?
| | Body Burden | 1 | 2016 | 7 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2017 | 284 | 0.030 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2016 | 46 | 0.030 |
Why?
| | Autopsy | 1 | 1997 | 94 | 0.030 |
Why?
| | Muridae | 1 | 1996 | 6 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2019 | 501 | 0.030 |
Why?
| | Interferon Regulatory Factors | 1 | 2017 | 44 | 0.030 |
Why?
| | Mean Platelet Volume | 1 | 2016 | 3 | 0.030 |
Why?
| | Transcription Factor AP-2 | 1 | 2016 | 82 | 0.030 |
Why?
| | Glycosaminoglycans | 1 | 2017 | 75 | 0.030 |
Why?
| | Allelic Imbalance | 1 | 2016 | 9 | 0.030 |
Why?
| | Geographic Information Systems | 1 | 2016 | 46 | 0.030 |
Why?
| | Erythrocyte Indices | 1 | 2016 | 33 | 0.030 |
Why?
| | Biopsy | 1 | 2020 | 1079 | 0.030 |
Why?
| | NADPH Oxidases | 1 | 2017 | 120 | 0.030 |
Why?
| | Blood Cell Count | 1 | 2016 | 55 | 0.030 |
Why?
| | Transportation | 1 | 2016 | 55 | 0.030 |
Why?
| | Proteoglycans | 1 | 2017 | 110 | 0.030 |
Why?
| | Drosophila | 1 | 2017 | 167 | 0.030 |
Why?
| | Proteolysis | 1 | 2017 | 170 | 0.030 |
Why?
| | Homicide | 1 | 1997 | 68 | 0.030 |
Why?
| | Quality Control | 1 | 2016 | 164 | 0.030 |
Why?
| | Glucose | 1 | 2021 | 1033 | 0.030 |
Why?
| | Bacterial Adhesion | 1 | 2016 | 110 | 0.030 |
Why?
| | Chromosomes, Human | 2 | 2009 | 41 | 0.030 |
Why?
| | Area Under Curve | 1 | 2016 | 329 | 0.030 |
Why?
| | Electrocardiography | 1 | 2019 | 664 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2002 | 1145 | 0.030 |
Why?
| | Diet | 1 | 2023 | 1270 | 0.030 |
Why?
| | Hedgehog Proteins | 1 | 2017 | 197 | 0.030 |
Why?
| | Genes, X-Linked | 1 | 2015 | 21 | 0.030 |
Why?
| | Parents | 1 | 2004 | 1395 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2020 | 643 | 0.030 |
Why?
| | Normal Distribution | 1 | 2015 | 22 | 0.030 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2017 | 376 | 0.030 |
Why?
| | Glucose-6-Phosphatase | 1 | 2015 | 31 | 0.030 |
Why?
| | Apolipoprotein A-V | 1 | 2014 | 4 | 0.030 |
Why?
| | Glycoproteins | 1 | 2017 | 353 | 0.030 |
Why?
| | Hypogonadism | 1 | 2015 | 90 | 0.030 |
Why?
| | Amides | 1 | 2015 | 99 | 0.030 |
Why?
| | Prevalence | 2 | 2013 | 2839 | 0.030 |
Why?
| | Molecular Sequence Data | 3 | 2012 | 2909 | 0.030 |
Why?
| | Environment | 1 | 2016 | 306 | 0.030 |
Why?
| | Cell Adhesion Molecules, Neuronal | 1 | 1995 | 42 | 0.030 |
Why?
| | Age Distribution | 1 | 2015 | 402 | 0.030 |
Why?
| | Birth Weight | 1 | 2017 | 506 | 0.030 |
Why?
| | Sex Distribution | 1 | 2015 | 386 | 0.030 |
Why?
| | ROC Curve | 1 | 2016 | 618 | 0.030 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2015 | 88 | 0.030 |
Why?
| | Population Surveillance | 1 | 2018 | 484 | 0.030 |
Why?
| | Echocardiography | 1 | 2017 | 644 | 0.030 |
Why?
| | Genetic Code | 1 | 2014 | 25 | 0.030 |
Why?
| | Proprotein Convertases | 1 | 2014 | 16 | 0.030 |
Why?
| | Animals | 8 | 2017 | 37948 | 0.030 |
Why?
| | Amino Acid Sequence | 2 | 2012 | 2136 | 0.030 |
Why?
| | Cattle | 1 | 2016 | 975 | 0.030 |
Why?
| | Mothers | 2 | 2010 | 765 | 0.030 |
Why?
| | Acyltransferases | 1 | 2014 | 78 | 0.020 |
Why?
| | Proprotein Convertase 9 | 1 | 2014 | 87 | 0.020 |
Why?
| | RNA Interference | 1 | 2015 | 473 | 0.020 |
Why?
| | Circadian Rhythm | 1 | 2018 | 510 | 0.020 |
Why?
| | Lipase | 1 | 2014 | 75 | 0.020 |
Why?
| | Video Games | 1 | 2013 | 30 | 0.020 |
Why?
| | Child, Preschool | 4 | 2009 | 11789 | 0.020 |
Why?
| | Scavenger Receptors, Class A | 2 | 2003 | 12 | 0.020 |
Why?
| | Serine Endopeptidases | 1 | 2014 | 129 | 0.020 |
Why?
| | Receptors, Scavenger | 2 | 2003 | 22 | 0.020 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 1993 | 60 | 0.020 |
Why?
| | Disease Outbreaks | 1 | 2016 | 423 | 0.020 |
Why?
| | Hexosyltransferases | 1 | 2012 | 6 | 0.020 |
Why?
| | Television | 1 | 2013 | 72 | 0.020 |
Why?
| | Confidence Intervals | 2 | 2003 | 331 | 0.020 |
Why?
| | International Agencies | 1 | 2012 | 30 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2025 | 6041 | 0.020 |
Why?
| | Prevotella nigrescens | 1 | 2012 | 1 | 0.020 |
Why?
| | Vesicle-Associated Membrane Protein 3 | 1 | 2012 | 2 | 0.020 |
Why?
| | Prevotella intermedia | 1 | 2012 | 2 | 0.020 |
Why?
| | Campylobacter rectus | 1 | 2012 | 2 | 0.020 |
Why?
| | Treponema denticola | 1 | 2012 | 2 | 0.020 |
Why?
| | Fusobacterium nucleatum | 1 | 2012 | 4 | 0.020 |
Why?
| | Bacteroides | 1 | 2012 | 20 | 0.020 |
Why?
| | Porphyromonas gingivalis | 1 | 2012 | 23 | 0.020 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2012 | 45 | 0.020 |
Why?
| | Aggregatibacter actinomycetemcomitans | 1 | 2012 | 27 | 0.020 |
Why?
| | Hematologic Diseases | 1 | 2012 | 66 | 0.020 |
Why?
| | Potassium Channels, Tandem Pore Domain | 1 | 2012 | 14 | 0.020 |
Why?
| | F-Box Proteins | 1 | 2012 | 23 | 0.020 |
Why?
| | Bacterial Load | 1 | 2012 | 67 | 0.020 |
Why?
| | Interleukin-33 | 1 | 2012 | 45 | 0.020 |
Why?
| | Nuclear Family | 2 | 2003 | 50 | 0.020 |
Why?
| | Fatty Acids | 1 | 2015 | 454 | 0.020 |
Why?
| | Principal Component Analysis | 1 | 2012 | 195 | 0.020 |
Why?
| | Nucleic Acid Hybridization | 1 | 2012 | 186 | 0.020 |
Why?
| | Dyslipidemias | 1 | 2014 | 182 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2012 | 393 | 0.020 |
Why?
| | Ambulatory Care | 2 | 1976 | 607 | 0.020 |
Why?
| | Neuropsychological Tests | 2 | 2007 | 1134 | 0.020 |
Why?
| | DNA Primers | 1 | 2012 | 507 | 0.020 |
Why?
| | Crosses, Genetic | 2 | 2005 | 124 | 0.020 |
Why?
| | Prenatal Diagnosis | 1 | 1993 | 196 | 0.020 |
Why?
| | Islets of Langerhans | 1 | 2018 | 842 | 0.020 |
Why?
| | Fetal Diseases | 1 | 1993 | 193 | 0.020 |
Why?
| | Liver | 1 | 2020 | 1889 | 0.020 |
Why?
| | Finland | 2 | 2001 | 78 | 0.020 |
Why?
| | Southeastern United States | 1 | 2010 | 37 | 0.020 |
Why?
| | Drinking Water | 1 | 2012 | 91 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 2012 | 347 | 0.020 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2012 | 191 | 0.020 |
Why?
| | Interleukins | 1 | 2012 | 248 | 0.020 |
Why?
| | Signal Transduction | 2 | 2015 | 5185 | 0.020 |
Why?
| | Recombination, Genetic | 3 | 1998 | 205 | 0.020 |
Why?
| | Waist Circumference | 1 | 2010 | 141 | 0.020 |
Why?
| | Hypertriglyceridemia | 1 | 2010 | 44 | 0.020 |
Why?
| | Fanconi Anemia Complementation Group Proteins | 1 | 2009 | 5 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1705 | 0.020 |
Why?
| | Menstruation | 1 | 2010 | 40 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2013 | 464 | 0.020 |
Why?
| | Glutathione S-Transferase pi | 1 | 2009 | 10 | 0.020 |
Why?
| | Trans-Activators | 1 | 2012 | 397 | 0.020 |
Why?
| | Mannose-Binding Lectin | 1 | 2009 | 20 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2012 | 503 | 0.020 |
Why?
| | Twins | 1 | 2010 | 152 | 0.020 |
Why?
| | Hypertension, Portal | 1 | 2009 | 66 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2012 | 1537 | 0.020 |
Why?
| | Body Composition | 1 | 2013 | 689 | 0.020 |
Why?
| | C-Peptide | 1 | 2010 | 190 | 0.020 |
Why?
| | Glucose Tolerance Test | 1 | 2010 | 360 | 0.020 |
Why?
| | Fanconi Anemia Complementation Group N Protein | 1 | 2008 | 4 | 0.020 |
Why?
| | Poly (ADP-Ribose) Polymerase-1 | 1 | 2009 | 53 | 0.020 |
Why?
| | Puberty | 1 | 2009 | 135 | 0.020 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2009 | 176 | 0.020 |
Why?
| | Educational Status | 1 | 2010 | 463 | 0.020 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2008 | 32 | 0.020 |
Why?
| | Intracranial Arteriosclerosis | 2 | 2006 | 8 | 0.020 |
Why?
| | Nutritional Status | 1 | 2010 | 351 | 0.020 |
Why?
| | Fathers | 1 | 2008 | 51 | 0.020 |
Why?
| | Monte Carlo Method | 2 | 2002 | 153 | 0.020 |
Why?
| | Longevity | 1 | 2009 | 175 | 0.020 |
Why?
| | Liver Cirrhosis | 1 | 2009 | 287 | 0.020 |
Why?
| | Isoenzymes | 1 | 2008 | 297 | 0.020 |
Why?
| | Interviews as Topic | 1 | 2011 | 905 | 0.020 |
Why?
| | Tunica Intima | 1 | 2006 | 78 | 0.020 |
Why?
| | Vitamin K Epoxide Reductases | 1 | 2006 | 11 | 0.020 |
Why?
| | Cytochrome P-450 CYP2C9 | 1 | 2006 | 19 | 0.020 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2006 | 8 | 0.020 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2006 | 15 | 0.010 |
Why?
| | International Normalized Ratio | 1 | 2006 | 52 | 0.010 |
Why?
| | Genetic Heterogeneity | 1 | 2006 | 65 | 0.010 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 1 | 2006 | 45 | 0.010 |
Why?
| | Sweden | 1 | 2006 | 111 | 0.010 |
Why?
| | Embolism | 1 | 2006 | 48 | 0.010 |
Why?
| | Weight Lifting | 1 | 2005 | 31 | 0.010 |
Why?
| | Arterial Occlusive Diseases | 1 | 2006 | 90 | 0.010 |
Why?
| | Carotid Arteries | 1 | 2006 | 207 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 1996 | 5967 | 0.010 |
Why?
| | DNA Probes | 2 | 1997 | 58 | 0.010 |
Why?
| | Mice, Inbred Strains | 1 | 2005 | 396 | 0.010 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2005 | 88 | 0.010 |
Why?
| | Statistical Distributions | 1 | 2004 | 7 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2006 | 1301 | 0.010 |
Why?
| | DNA Replication | 1 | 2006 | 252 | 0.010 |
Why?
| | Adult Children | 1 | 2003 | 27 | 0.010 |
Why?
| | Likelihood Functions | 1 | 2003 | 139 | 0.010 |
Why?
| | Consanguinity | 2 | 1994 | 49 | 0.010 |
Why?
| | Radiography | 1 | 2006 | 848 | 0.010 |
Why?
| | Systole | 1 | 2003 | 177 | 0.010 |
Why?
| | Skin Tests | 1 | 2003 | 94 | 0.010 |
Why?
| | Minisatellite Repeats | 1 | 2003 | 36 | 0.010 |
Why?
| | X-ray Repair Cross Complementing Protein 1 | 1 | 2003 | 14 | 0.010 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2003 | 63 | 0.010 |
Why?
| | Heart Diseases | 1 | 2006 | 341 | 0.010 |
Why?
| | 3' Untranslated Regions | 1 | 2003 | 150 | 0.010 |
Why?
| | Cell Line | 2 | 2002 | 2821 | 0.010 |
Why?
| | RNA, Neoplasm | 1 | 2002 | 83 | 0.010 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2004 | 580 | 0.010 |
Why?
| | Mice | 4 | 2005 | 18261 | 0.010 |
Why?
| | Transduction, Genetic | 1 | 2002 | 131 | 0.010 |
Why?
| | Carcinoma, Intraductal, Noninfiltrating | 1 | 2002 | 61 | 0.010 |
Why?
| | Carcinoma, Lobular | 1 | 2002 | 55 | 0.010 |
Why?
| | Reference Values | 1 | 2003 | 794 | 0.010 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2002 | 223 | 0.010 |
Why?
| | Tamoxifen | 1 | 2002 | 191 | 0.010 |
Why?
| | Base Sequence | 2 | 1995 | 2177 | 0.010 |
Why?
| | Phylogeny | 1 | 2005 | 1024 | 0.010 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2002 | 192 | 0.010 |
Why?
| | Isoelectric Point | 1 | 1980 | 23 | 0.010 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2002 | 427 | 0.010 |
Why?
| | Cell Division | 1 | 2002 | 753 | 0.010 |
Why?
| | Matched-Pair Analysis | 1 | 2000 | 37 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2002 | 881 | 0.010 |
Why?
| | Walking | 1 | 2005 | 542 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2005 | 1207 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2002 | 849 | 0.010 |
Why?
| | Biological Assay | 1 | 1980 | 128 | 0.010 |
Why?
| | Cyclothymic Disorder | 2 | 1976 | 5 | 0.010 |
Why?
| | Renal Dialysis | 1 | 2003 | 465 | 0.010 |
Why?
| | Kinetics | 1 | 2002 | 1603 | 0.010 |
Why?
| | Internet | 1 | 2004 | 698 | 0.010 |
Why?
| | Founder Effect | 1 | 1998 | 13 | 0.010 |
Why?
| | Ovarian Neoplasms | 1 | 2004 | 589 | 0.010 |
Why?
| | Aging | 1 | 2009 | 1938 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2006 | 2922 | 0.010 |
Why?
| | Death Certificates | 1 | 1997 | 32 | 0.010 |
Why?
| | Accidents | 1 | 1997 | 46 | 0.010 |
Why?
| | Dibenzocycloheptenes | 1 | 1976 | 5 | 0.010 |
Why?
| | Malpractice | 1 | 1997 | 44 | 0.010 |
Why?
| | Fluspirilene | 1 | 1976 | 1 | 0.010 |
Why?
| | Penfluridol | 1 | 1976 | 1 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2006 | 17147 | 0.010 |
Why?
| | Fluphenazine | 1 | 1976 | 4 | 0.010 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 1996 | 68 | 0.010 |
Why?
| | Nail-Patella Syndrome | 1 | 1976 | 1 | 0.010 |
Why?
| | Therapeutic Equivalency | 1 | 1976 | 31 | 0.010 |
Why?
| | Remission, Spontaneous | 1 | 1976 | 39 | 0.010 |
Why?
| | Depression | 2 | 1976 | 1561 | 0.010 |
Why?
| | Viral Vaccines | 1 | 1997 | 107 | 0.010 |
Why?
| | Haloperidol | 1 | 1976 | 33 | 0.010 |
Why?
| | Costa Rica | 1 | 1995 | 18 | 0.010 |
Why?
| | ABO Blood-Group System | 1 | 1976 | 55 | 0.010 |
Why?
| | Diagnostic Errors | 1 | 1997 | 177 | 0.010 |
Why?
| | Paranoid Disorders | 1 | 1975 | 2 | 0.010 |
Why?
| | Hallucinations | 1 | 1975 | 31 | 0.010 |
Why?
| | Macrophages | 1 | 2002 | 1496 | 0.010 |
Why?
| | Genes | 1 | 1995 | 226 | 0.010 |
Why?
| | Swine | 1 | 1997 | 828 | 0.010 |
Why?
| | Cause of Death | 1 | 1997 | 464 | 0.010 |
Why?
| | Delayed-Action Preparations | 1 | 1975 | 184 | 0.010 |
Why?
| | Long-Term Care | 1 | 1975 | 117 | 0.010 |
Why?
| | Hybrid Cells | 1 | 1993 | 49 | 0.010 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 1993 | 19 | 0.010 |
Why?
| | DNA, Complementary | 1 | 1993 | 273 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 1993 | 318 | 0.010 |
Why?
| | Cells, Cultured | 1 | 1980 | 4110 | 0.010 |
Why?
| | Turkey | 1 | 1992 | 21 | 0.010 |
Why?
| | Chromosome Banding | 1 | 1992 | 17 | 0.010 |
Why?
| | Blotting, Southern | 1 | 1992 | 84 | 0.010 |
Why?
| | Ataxia | 1 | 1992 | 69 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 1975 | 1044 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2002 | 2753 | 0.010 |
Why?
| | Microcephaly | 1 | 1992 | 104 | 0.010 |
Why?
| | Cataract | 1 | 1992 | 212 | 0.000 |
Why?
| | Cysticercosis | 1 | 1969 | 3 | 0.000 |
Why?
| | Suicide | 1 | 1997 | 725 | 0.000 |
Why?
| | Wounds and Injuries | 1 | 1997 | 960 | 0.000 |
Why?
| | Diagnosis, Differential | 1 | 1992 | 1501 | 0.000 |
Why?
| | Brain Diseases | 1 | 1969 | 152 | 0.000 |
Why?
| | Adjustment Disorders | 1 | 1976 | 5 | 0.000 |
Why?
| | Psychophysiologic Disorders | 1 | 1976 | 10 | 0.000 |
Why?
| | Neurocognitive Disorders | 1 | 1976 | 33 | 0.000 |
Why?
| | Computers | 1 | 1976 | 67 | 0.000 |
Why?
|
|
Lange's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|